Emergent BioSolutions EBS Cash Flow Statement (2010-2026)

NYSE EBS
$6.07 -0.03 (-0.49%)
As of: Nov 10, 2026 · 12:21 PM EST
Reported Financials

Emergent BioSolutions Quarterly Cash Flow Statement

Periods 65 quarters
Latest Sep 2026

Emergent BioSolutions reported cash from operations of $100.10M and free cash flow of $96.80M for the quarter ended Sep 2026. This cash flow statement covers 65 quarters of results from Sep 2010 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
193.10M-4.60M-52.90M-87.10M-67.00M-186.20M-261.40M-263.40M-49.50M9.00M-283.10M114.80M-31.30M68.00M-12.00M51.20M-54.60M6.80M-180.20M-32.70M
Depreciation and DepletionDep. & Depletion
15.70M16.60M28.50M20.30M18.00M17.60M16.80M11.70M13.40M11.70M12.20M10.10M9.70M9.10M7.30M7.10M7.20M7.00M6.80M6.40M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
1.00M1.00M1.00M1.10M1.00M1.00M8.90M5.70M5.70M6.90M5.00M-6.70M2.20M2.30M2.40M2.50M2.60M1.80M1.60M1.60M
Depreciation & Amortization (CF)Dep. & Amort.
29.20M30.90M44.50M32.20M35.70M34.60M32.90M28.00M29.60M27.90M28.50M26.40M26.00M25.40M23.50M23.40M23.50M23.50M24.00M17.00M
Share-based CompensationStock Comp.
10.10M9.90M12.30M11.20M11.70M6.80M8.30M4.00M4.00M5.90M5.50M2.30M4.30M1.50M4.60M4.80M5.30M1.90M6.90M4.20M
Deferred Taxes
45.40M1.90M0.70M22.90M-54.10M-4.70M-1.70M2.70M-5.20M-12.20M-0.20M7.30M-0.40M18.60M-13.90M-10.20M1.50M-4.50M2.10M-13.20M
Gains from Sales and DivestituresGains Divest
-3.60M74.90M-0.70M-7.20M-40.00M11.10M0.20M-12.20M8.70M-1.00M-0.80M-10.70M
Asset Writedowns and ImpairmentWritedown
41.70M6.70M306.70M218.20M27.20M12.20M191.30M
Other non-cash itemsOther Non-Cash
-20.00M1.10M1.30M0.60M-10.00M0.30M0.40M-1.10M-5.00M-2.90M0.10M-0.30M4.80M-20.80M4.10M29.70M-12.30M20.50M-6.70M
Change in Working Capital
Change in ReceivablesChange Receivables
-98.50M-93.70M-4.00M15.20M-35.60M-2.60M132.40M-71.30M-36.90M50.00M-20.40M-82.30M77.10M73.30M-118.50M71.60M-51.90M38.90M68.80M-112.60M
Change in InventoryChange Inventory
8.60M50.10M25.40M27.30M-45.70M30.70M-5.80M0.10M-25.60M4.50M13.00M18.00M-11.00M2.20M24.70M17.60M-14.20M-15.80M-24.00M-22.80M
Change in Account PayablesChange Payables
-5.10M-14.70M7.10M-4.20M-2.20M31.00M-20.10M6.80M-7.10M-2.40M2.60M-23.00M-10.20M-5.40M-10.40M-4.00M11.40M-14.40M10.00M1.40M
Change in Accrued ExpensesChange Accrued Exp.
10.10M-51.00M14.60M-12.00M-18.30M-24.30M10.50M-16.40M-25.50M-33.30M26.30M39.90M-51.10M-32.20M3.90M1.30M9.70M-20.20M4.20M5.10M
Change in TaxesChange Taxes
-5.50M-40.90M-4.60M79.70M12.90M1.30M-17.70M-12.70M16.10M10.50M-3.30M-8.40M6.80M6.20M-6.30M4.60M-0.30M0.10M
Change in Other Operating AssetsOther Assets Change
-62.50M16.60M2.80M14.90M-14.40M4.50M13.30M0.50M-30.00M6.00M-166.00M13.70M-23.60M-9.50M-19.70M2.10M15.40M0.50M0.10M-0.20M
Change in Other Operating LiabilitiesOther Liabilities Change
-12.30M-2.00M4.70M1.50M5.40M-8.40M0.70M9.50M4.10M-19.70M0.20M0.70M-1.50M-0.30M0.20M1.20M4.10M3.20M3.30M-0.60M
Other Working Capital ChangesOther WC Changes
50.20M-18.60M1.90M-13.40M19.80M-12.90M-12.60M9.00M34.10M-25.70M166.20M-13.00M22.10M9.20M19.90M-0.90M-11.30M2.70M3.20M-0.40M
Cash from OperationsCash from Ops.
328.10M-37.30M-15.60M-74.00M92.80M-184.00M-114.40M60.00M32.10M-62.60M47.50M153.70M-79.90M-11.20M106.40M-2.30M77.70M-33.80M56.10M100.10M
Investing Activities
Capital ExpendituresCapex
45.80M32.20M32.10M271.60M23.60M15.10M12.50M12.60M11.40M10.80M4.60M5.80M1.70M3.60M2.90M3.40M3.90M2.40M2.10M3.30M
Sales of Property, Plant and EquipmentPP&E (Sale)
7.60M0.30M38.10M0.10M0.20M5.40M
Change in Property, Plant and EquipmentChange in PP&E
-45.80M-32.20M-32.10M-271.60M-23.60M-15.10M-12.50M-12.60M-11.40M-10.80M-4.60M1.80M-1.40M34.50M-2.80M-3.40M-3.90M-2.40M-1.90M2.10M
Acquisitions
Divestments
74.90M110.20M
Net of Acquisitions & DivestmentsNet Acquisitions
74.90M110.20M
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Other Investing Activities (as filed)Other investing (as filed)
6.30M-5.00M
Cash from Investing ActivitiesCash from Investing
-45.80M-32.20M-32.10M-271.60M-45.40M-15.10M257.70M-18.90M-11.40M-10.80M-4.60M112.00M28.60M59.50M17.20M-3.40M-3.90M-2.40M-52.30M4.60M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
360.00M20.00M50.00M15.00M219.00M2.20M
Long-Term Debt RepaymentsLT Debt Repayment
8.40M8.50M8.40M8.40M8.50M8.40M148.40M3.90M3.90M3.90M4.00M190.30M6.90M101.80M-81.90M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-8.40M-8.50M-8.40M-8.40M351.50M-8.40M-148.40M-3.90M16.10M46.10M11.00M28.70M-6.90M-99.60M81.90M
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
347.80M39.00M12.00M5.00M56.50M222.70M
Net Short-Term Debt Issued (Repaid)Net ST Debt
-347.80M-39.00M-12.00M-5.00M-56.50M-222.70M
Net Debt Issuances and RepaymentsNet Debt Issuance
-8.40M-8.50M-8.40M-8.40M351.50M-8.40M-496.20M-42.90M4.10M41.10M-45.50M-194.00M-6.90M-99.60M81.90M
Change in Capital Stock
Common Stock IssuedStock Issued
3.40M0.50M2.50M2.00M9.50M0.70M0.70M13.40M0.80M0.10M0.70M0.20M-1.00M0.40M1.00M0.10M
Shares Repurchased
106.00M57.50M24.40M0.20M6.90M8.90M9.10M9.00M9.00M0.10M
Net Shares Issued and RepurchasedNet Shares Issued
-102.60M-57.00M-21.90M1.80M9.50M0.70M0.70M13.40M0.80M0.10M-6.20M-8.70M-10.10M-8.60M-8.00M
Net Equity Issued and RepurchasedNet Equity Issued
-102.60M-57.00M-21.90M1.80M9.50M0.70M0.70M13.40M0.80M0.10M-6.20M-8.70M-10.10M-8.60M-8.00M
Other financing activities (as filed)
1.00M-5.00M-0.40M-0.30M-0.20M-2.10M-0.20M-0.10M-0.10M-0.40M-6.10M-9.00M-0.30M-0.50M-0.20M-0.30M-4.20M-2.80M-11.90M-0.20M
Cash from Financing ActivitiesCash from Financing
-110.00M-70.50M-30.70M229.30M353.10M-10.50M-486.90M-43.00M4.70M40.70M-50.90M-180.30M0.50M-0.40M-6.40M-15.90M-113.90M-11.40M-24.40M-68.70M
Additional items
Exchange Rate EffectFX Effect
-0.30M0.70M-1.00M1.10M-0.20M-0.60M1.10M-1.50M-0.70M1.00M-0.20M
Change in Cash
172.30M-140.30M-77.70M-117.30M401.60M-209.80M-344.20M-0.80M23.90M-32.70M-8.00M85.40M-50.80M47.20M118.20M-21.80M-40.10M-47.60M-20.60M36.00M
Ending Cash Balance
576.30M436.00M358.30M241.00M642.60M430.20M88.60M87.80M111.70M79.00M71.00M156.40M105.60M152.80M271.00M249.20M209.10M161.50M140.90M176.90M
Free Cash FlowFCF
282.30M-69.50M-47.70M-345.60M69.20M-199.10M-126.90M47.40M20.70M-73.40M42.90M147.90M-81.60M-14.80M103.50M-5.70M73.80M-36.20M54.00M96.80M
Net Cash FlowNCF
172.30M-140.00M-78.40M-116.30M400.50M-209.60M-343.60M-1.90M25.40M-32.70M-8.00M85.40M-50.80M47.90M117.20M-21.60M-40.10M-47.60M-20.60M36.00M
Interest Paid
3.10M11.70M3.10M11.90M6.30M21.60M17.20M17.70M11.80M21.50M14.50M19.80M8.20M16.70M8.10M16.90M8.00M13.10M3.50M13.00M
Income Taxes PaidTaxes Paid
14.00M4.80M15.20M3.90M-17.70M16.70M10.20M11.40M14.50M12.40M13.50M9.60M-9.00M14.50M2.10M10.90M12.50M5.30M4.30M12.30M

Emergent BioSolutions Cash Flow Statement API

Pull Emergent BioSolutions's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EBS&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY